ERP016370
Study Detail
| Title | Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib |
| Study Type | Other |
| Abstract | Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR). |
| Description | Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR). |
| Center Name | Astex Pharmaceuticals |
SRA Links
| Url Link | E-MTAB-4851 in ArrayExpress |
Navigation
|
Submission | ERA673596 |
 FTP
|
|
|
Experiment | ERX1589911 |
FASTQ
|
SRA
|
| ERX1589912 |
FASTQ
|
SRA
|
||
| ERX1589913 |
FASTQ
|
SRA
|
||
| ERX1589914 |
FASTQ
|
SRA
|
||
| ERX1589915 |
FASTQ
|
SRA
|
||
| ERX1589916 |
FASTQ
|
SRA
|
||
| ERX1589917 |
FASTQ
|
SRA
|
||
|
|
Sample | ERS1237150 | ||
| ERS1237151 | ||||
| ERS1237152 | ||||
| ERS1237153 | ||||
| ERS1237154 | ||||
| ERS1237155 | ||||
| ERS1237156 |